BioInvent's PIPE Round

BioInvent raised a round of funding on December 21, 2016. Investors include Pfizer.

BioInvent is translating cancer antibody biology into immuno-oncology therapies. Based on its insights in immunology, cancer biology, and antibody biology, BioInvent aims to develop cancer immunothera…

Articles about BioInvent's PIPE Round: